Zimmer Financial Statements From 2010 to 2025

ZIM Stock   98.88  1.97  1.95%   
Zimmer Biomet financial statements provide useful quarterly and yearly information to potential Zimmer Biomet Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Zimmer Biomet financial statements helps investors assess Zimmer Biomet's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Zimmer Biomet's valuation are summarized below:
Zimmer Biomet Holdings does not presently have any fundamental gauges for analysis.
Check Zimmer Biomet financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zimmer Biomet's main balance sheet or income statement drivers, such as , as well as many indicators such as . Zimmer financial statements analysis is a perfect complement when working with Zimmer Biomet Valuation or Volatility modules.
  
This module can also supplement various Zimmer Biomet Technical models . Check out the analysis of Zimmer Biomet Correlation against competitors.

Zimmer Biomet Holdings Company EBITDA Analysis

Zimmer Biomet's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Zimmer Biomet EBITDA

    
  1.49 B  
Most of Zimmer Biomet's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zimmer Biomet Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition
According to the company disclosure, Zimmer Biomet Holdings reported earnings before interest,tax, depreciation and amortization of 1.49 B. This is much higher than that of the sector and significantly higher than that of the EBITDA industry. The ebitda for all Germany stocks is notably lower than that of the firm.

Zimmer Biomet Holdings Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Zimmer Biomet's current stock value. Our valuation model uses many indicators to compare Zimmer Biomet value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Zimmer Biomet competition to find correlations between indicators driving Zimmer Biomet's intrinsic value. More Info.
Zimmer Biomet Holdings is rated second in current valuation category among its peers. It is rated first in price to book category among its peers . The ratio of Current Valuation to Price To Book for Zimmer Biomet Holdings is about  13,850,304,602 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Zimmer Biomet's earnings, one of the primary drivers of an investment's value.

About Zimmer Biomet Financial Statements

Zimmer Biomet shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Zimmer Biomet investors may analyze each financial statement separately, they are all interrelated. The changes in Zimmer Biomet's assets and liabilities, for example, are also reflected in the revenues and expenses on on Zimmer Biomet's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Zimmer Stock Analysis

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.